Recruiting
Phase 1
Phase 2

A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas

Sponsor:

Constellation Pharmaceuticals

Code:

NCT04104776

Conditions

Advanced Solid Tumor

Diffuse Large B Cell Lymphoma

Lymphoma, T-Cell

Mesothelioma, Malignant

Prostatic Neoplasms, Castration-Resistant

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CPI-0209

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information